Evaluation of the risk of antipsychotic-induced metabolic disturbances: possibilities of pharmacogenetic testing
R.F. NASYROVA1, D.V. IVASHCHENKO1, K.K. YAKHIN2, N.G. NEZNANOV1 1St.-Petersburg V.M. Bekhterev Research Psychoneurological Institute, 3 Bekhterev Str., Saint-Petersburg, Russian Federation, 192019 2Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012 Nasyrova R.F. ― D. Med. Sc., Head of the Department of Personalized Psychiatry and Neurology, tel. (812) 670-02-37, e-mail: reginaf@bekhterev.ru Ivashchenko D.V. ― […]